TAKE THIS POLL |
|
|
- Anti-Doping Agency investigates new doping techniques 3 Jul 2008 06:52 GMT
... used by cheats at the Beijing Olympics. The World Anti-Doping Agency is looking into gene therapy, where an athlete's DNA might be treated to improve healing times and to boost ...
- 10,000 people in world-first cerebral palsy study 2 Jul 2008 20:25 GMT
... to cerebral palsy, specific disease preventions may be available for individuals. "In the future, gene therapy may allow doctors to alter the aberrant genes in a mother or fetus, or ...
- Introgen: Advexin to face regulatory hurdles and increasing skepticism 2 Jul 2008 14:54 GMT
... of the Atlantic. However, Introgen may struggle to convince the regulatory authorities that the gene therapy drug will offer an improvement in the treatment of head and neck cancer. While ...
- Intra Uterine Growth Retardation Induced Sub-Fertility Is Corrected By Placental Gene Therapy With Insulin-Like Growth Factor-1 2 Jul 2008 11:16 GMT
... that IUGR induced sub-fertility could be corrected if IUGR could be corrected by placental gene therapy. A model of intrauterine growth retardation (rats) (uterine artery ligation) with without recombinant adenoviral ...
- Taming, Then Aiming, Viruses At Brain Tumors - "Engineered" Viruses May Hold Promise For Cancer Treatment 2 Jul 2008 07:33 GMT
... of Tumors Induces Angiogenesis and Upregulates CYR61 Molecular Therapy , The American Society of Gene Therapy, ...
- 6 scientists scout Treasure Coast for biotech institute seeking new home 2 Jul 2008 05:10 GMT
... research would dovetail with the work of Oregon Health & Science University's Vaccine and Gene Therapy Institute, which announced its own move to Port St. Lucie in January. The news ...
- Gender Differences and Heart Disease 1 Jul 2008 21:31 GMT
... first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial for gene therapy for Parkinson's disease, the first indication of bone marrow's critical role in tumor growth, ...
- Following Traumatic Brain Injury, Balanced Nutrition Saves Lives 1 Jul 2008 21:31 GMT
... first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial for gene therapy for Parkinson's disease, the first indication of bone marrow's critical role in tumor growth, ...
- Gene Therapy Files for Approval 1 Jul 2008 20:51 GMT
... has filed applications with FDA and EMEA for marketing approval of , its new gene therapy for cancer. The product, which grew out of research at the M.D. Anderson Cancer ...
- Case Western, Copernicus Therapeutics, and Polygenix Are Recipients of $3.9M from the Ohio Department of Development 1 Jul 2008 17:50 GMT
... will cover development of nanoparticles for treatment of cystic fibrosis and retinitis pigmentosa using gene therapy technology from Copernicus. It will also include commercialization of Polygenix’ two-photon ophthalmoscope for early ...
- Case Western, Copernicus Therapeutics, and Polygenix Are Receipients of $3.9M from the Ohio Department of Development 1 Jul 2008 17:13 GMT
... will cover development of nanoparticles for treatment of cystic fibrosis and retinitis pigmentosa using gene therapy technology from Copernicus. It will also include commercialization of Polygenix’ two-photon ophthalmoscope for early ...
- Total Systems posts profit 1 Jul 2008 16:14 GMT
... will be similar to the year ended 31 March 2008,” said chairman Terence Bourne. Gene therapy group Oxford Biomedica said Bavarian Nordic has filed a patent infringement action in the ...
- Oxford Biomedica gets infringement suit from Danish firm 1 Jul 2008 12:50 GMT
... LONDON (SHARECAST) - Gene therapy group Oxford Biomedica said Bavarian Nordic has filed a patent infringement action in the ...
- RESPONSE TO BAVARIAN NORDIC'S 1 Jul 2008 08:55 GMT
... Oxford BioMedica (LSE: OXB), a leading gene therapy company, today announces that it has been informed that Bavarian Nordic filed a patent ...
- QIAGEN Acquires Corbett Life Science 1 Jul 2008 06:19 GMT
... research markets and proteomics markets, nucleic acid-based molecular diagnostics market, and genetic vaccination and gene therapy markets, competition, rapid or unexpected changes in technologies, fluctuations in demand for QIAGEN's, products ...
- Alzheimer's Drug Shows Early Promise 1 Jul 2008 04:27 GMT
... FRIDAY, June 27 (HealthDay News) -- Long-anticipated results from a trial on an experimental Alzheimer's therapy ...
- Introgen's Advexin Gene Therapy Filings Are First of Their Kind 1 Jul 2008 01:51 GMT
... Introgen's Advexin Gene Therapy Filings Are First of Their Kind Introgen Therapeutics Inc. made history Monday when it ...
- Introgen Submits Advexin Regulatory Applications in the U.S. and Europe 1 Jul 2008 00:31 GMT
... for the approved indication. "This is an important milestone in the clinical application of gene therapy for cancer patients," said Jack A. Roth, MD, inventor of Advexin and Professor and ...
- Experts describe promise of nanotech for cancer detection, more 30 Jun 2008 22:31 GMT
... new techniques that researchers in his lab are using to create delivery systems for gene therapy and RNA interference. They have developed new ways to quickly synthesize a vast array ...
- Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe 30 Jun 2008 21:12 GMT
... ...
1 - 25 of 80 next >
News by PR Newswire
|
